Gene · 1673
Papers4,248
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 4,248
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| BRD4 binds the nucleosome via both histone and DNA interactions. | bioRxiv | 2025 | 40501777 | PubTator, text mining | PubMed |
| Effect of dupilumab for the therapy of atopic dermatitis and the effect on serum TARC, HBD2 and SEA-IgE levels and peripheral blood T helper cell subtypes. | Exp Ther Med | 2025 | 40462855 | PubTator, text mining | PubMed |
| Comparison of salivary statherin and beta-defensin-2 levels, oral health behaviors, and demographic factors in children with and without early childhood caries. | BMC Oral Health | 2025 | 40450305 | PubTator, text mining | PubMed |
| Impact of antibacterial therapeutic agents on biofilm-tissue interactions in a 3D implant-tissue-oral-bacterial-biofilm model. | Sci Rep | 2025 | 40447792 | PubTator, text mining | PubMed |
| Human beta defensin-2 protects the epithelial barrier during methicillin-resistant Staphylococcus aureus infection in chronic rhinosinusitis with nasal polyps. | Front Cell Infect Microbiol | 2025 | 40415954 | PubTator, text mining | PubMed |
| Clinical, metabolic, and immune interaction between tuberculosis and diabetes mellitus: implications and opportunities for therapies. | Expert Opin Pharmacother | 2025 | 40401906 | PubTator, text mining | PubMed |
| Alginate-based hydrogels for sustained antimicrobial peptide delivery to enhance wound healing in diabetes. | Biomater Adv | 2025 | 40359773 | PubTator, text mining | PubMed |
| BD2: A roadmap for learning health networks driving care improvement in bipolar disorder. | J Affect Disord | 2025 | 40345447 | PubTator, text mining | PubMed |
| Lysine-Targeting, Covalent Inhibitors of Bromodomain BD1 of BET Proteins in Live Cells and Animals. | Angew Chem Int Ed Engl | 2025 | 40313007 | PubTator, text mining | PubMed |
| Design, synthesis, and biological evaluation of novel CDK4/6 and BRD4 dual inhibitors for treatment of KRAS-mutant NSCLC. | Eur J Med Chem | 2025 | 40311163 | PubTator, text mining | PubMed |
| Harnessing the Power of Probiotics: Boosting Immunity and Safeguarding against Various Diseases and Infections. | Recent Adv Antiinfect Drug Discov | 2025 | 40302548 | PubTator, text mining | PubMed |
| Immune responses to vaginal candidiasis in African women: A scoping review of cytokine profiles, T-cell activation, and gene expression. | PLoS One | 2025 | 40267085 | PubTator, text mining | PubMed |
| HPV16 E7 inhibits HBD2 expression by down-regulation of ASK1-p38 MAPK pathway in cervical cancer. | Virol J | 2025 | 40253372 | PubTator, text mining | PubMed |
| IL-17 Ligand and Receptor Family Members Are Differentially Expressed by Keratinocyte Subpopulations and Modulate Their Differentiation and Inflammatory Phenotype. | Int J Mol Sci | 2025 | 40243580 | PubTator, text mining | PubMed |
| Repurposing of activating transcription factor 3 (ATF3) activator molecules with potential wound-healing effects. | Injury | 2025 | 40220516 | PubTator, text mining | PubMed |
| Redox regulation of cutaneous AMPs by ozone in tensioned skin models. | Arch Biochem Biophys | 2025 | 40189003 | PubTator, text mining | PubMed |
| Harnessing immunotherapeutic molecules and diagnostic biomarkers as human-derived adjuvants for MERS-CoV vaccine development. | Front Immunol | 2025 | 40181980 | PubTator, text mining | PubMed |
| Editorial for the Special Issue "Cutaneous Biology, Molecular Dermatology and Dermatopathology". | Int J Mol Sci | 2025 | 40141335 | PubTator, text mining | PubMed |
| Macrocyclic dihydropyridine analogs as pan-BET BD2-preferred inhibitors. | Eur J Med Chem | 2025 | 40120495 | PubTator, text mining | PubMed |
| Isolation of dihydroagarofuran sesquiterpene from the fruits of Tripterygium hypoglaucum and evaluation of their anti-inflammatory activity. | Phytochemistry | 2025 | 40118309 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1673/papers?page=6